Newsroom

Literature

Circulating tumor DNA (ctDNA) monitoring in breast cancer patients receiving neoadjuvant palbociclib and endocrine therapy. A secondary analysis of the NeoRHEA phase 2 study

ASCO 2023
Presented
Jun 3, 2023
Type
Poster

LIBELULE: A randomized phase III study to evaluate the clinical relevance of early liquid biopsy (LB) in patients with suspicious metastatic lung cancer

ASCO 2023
Presented
Jun 3, 2023
Type
Poster

A phase II single-arm, open-label trial of T-DM1 (ado-trastuzumab emtansine) and neratinib for HER2-positive breast cancer with molecular residual disease (KAN-HER2 MRD)

ASCO 2023
Presented
Jun 2, 2023
Type
Poster

Detection of circulating tumor DNA following neoadjuvant chemotherapy and surgery to anticipate early relapse in ER positive and HER2 negative breast cancer: Analysis from the PENELOPE-B trial

ASCO 2023
Presented
Jun 2, 2023
Type
Abstract

Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC)

ASCO 2023
Presented
Jun 2, 2023
Type
Poster

Validation of recurrence prediction using circulating tumor DNA in patients with curatively treated early stage non-small cell lung cancer

ASCO 2023
Presented
Jun 2, 2023
Type
Poster

Spatial Analysis of Genomic Signatures on Colorectal Cancer Pathogenesis Using the NanoString GeoMx® Digital Spatial Profiler

AACR 2023
Presented
Apr 19, 2023
Type
Poster

Bridging the gap between targeted NGS and FISH gene-level CNV detection capabilities in hematologic malignancies

AACR 2023
Presented
Apr 18, 2023
Type
Poster

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients